Huge news coming in the world of health and science as the first ever blood biomarker for Multiple Sclerosis (MS) has been discovered.
While MS has no known cure, it does have several subtypes that can drastically depict the treatments going forward. Currently, there is a long waiting period before identifying the actual subtype that exists. This process not only takes time, but is quite expensive and can ultimately decide the effectiveness of treatment. After 12 years of research, there has finally been a breakthrough in which scientists identified a biomarker that can decipher MS subtypes with a simple blood test.
This discovery is crucial to expediting the diagnosis and allowing for quicker and more accurate treatment. Not only can the MS subtype be identified early on, but this opens the door for quicker and more effective treatments.
It is said to be an 85 to 90 percent accurate test as well as gives high hopes for furthering the research into personalized treatments for MS.
There is expected to be a blood kit available to test for MS subtypes within two years.
Furthermore, this blood biomarker involves Tryptophan, known to be involved in brain inflammation, which gives promise for potential insights into other brain inflammatory diseases such as Parkinson’s, Alzheimer's, and other neurodegenerative disease.
The Scientific Publishing Can Be Found In The Journal, Scientific Reports.
The News Source Can Be Found At Macquarie University.